Geneseeq
Toronto
About Geneseeq
Established in 2008, Geneseeq is an industry leader in Next-Generation Sequencing (NGS) fully committed to the research and clinical translation of NGS Genetic Sequencing in the field of personalized medicine. Geneseeq’s world-leading laboratories have successfully passed China’s National Center of Clinical Laboratories(NCCL) External Quality Assessment(EQA), College of American Pathologists(CAP) PT, European Molecular Genetics Quality Network(EMQN) PT, and received 3rd party medical laboratory and clinical PCR amplification laboratory qualifications.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 501 – 1,000
- Total funding: $135.7M
- Funding stage: Late Stage Venture
- Last round: Series D (Dec 2019)
- Website: na.geneseeq.com
- Phone: 400-636-2325
Industries & Categories
Biotechnology, Clinical Trials, Health Care, Life Science, Oncology
Social Profiles
Canonical: https://fsome.com/organization/geneseeq-71957 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.